ME
23andMe Holding Co.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$0.61
+0.00%Price chart
Jul 7Jul 10Nov 25Mar 2Mar 10Mar 13Mar 18Mar 23
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.0x
Market Cap
$16.66M
MomentumView details →
1D Return
+0.00%
YTD Return
—
RSI (14)
25.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.0x
Market Cap
$16.66M
RSI (14)
25.3
MomentumView details →
1D Return
+0.00%
YTD Return
—
Similar companies
Latest newsMore news →
Eskom extended a discounted tariff of 62c/kWh to support resumption of production by smelters owned by Samancor Chrome and the Glencore-Merafe Chrome Venture, and entered an undisclosed discounted negotiated pricing agreement with Manganese Metal Company.4d agoU.S. Bankruptcy Judge Brian Walsh ruled that California cannot seek monetary damages from Chrome Holding Co (formerly 23andMe) over a 2023 data breach, but may pursue non-monetary remedies.56d ago